Vynyl Principal Chris Hoyd recently sat down with Amit Shah, COO of Virta Health, to discuss how his team is transforming the treatment of type 2 diabetes and other chronic metabolic conditions. Virta Health has grown from around 20 people when Amit joined to over 500 now, demonstrating impressive scale and impact.
![Virta company retreat with team members posing for group photo outside](https://images.prismic.io/vynyl-marketing/ZpBugx5LeNNTxEnk_VirtaTeamRetreat.jpg?auto=format%2Ccompress&fit=min)
Amit shared how Virta's unique approach combines personalized nutrition, continuous monitoring, and clinical support through a tech platform to achieve sustainable lifestyle changes without medication or surgery. By putting 100% of their fees at risk, Virta has demonstrated their commitment to delivering transformational outcomes.
![woman interacting with a Virta expert via chat on a laptop](https://images.prismic.io/vynyl-marketing/ZpBuxB5LeNNTxEn8_HealthCoach01.jpg?auto=format%2Ccompress&fit=min)
A few takeaways from the conversation:
- Virta's innovative model integrates technology and clinician care to deliver significant improvements in weight loss and A1C reduction while eliminating or reducing the use of drugs like insulin and GLP1s.
- The company leverages a unique dataset and machine learning models to predict and provide personalized interventions for patients, enhancing engagement and outcomes.
- Recent developments in GLP-1 drugs have created a tailwind for Virta, positioning them as a sustainable alternative for long-term weight management and metabolic health improvement.
![man reading recipe book in kitchen with Virta Starter Kit next to him on the counter](https://images.prismic.io/vynyl-marketing/ZpBvTR5LeNNTxEor_VirtaStarterKit05.jpg?auto=format%2Ccompress&fit=min)
For anyone interested in the future of chronic disease management and digital health innovation, this conversation is full of applicable insights and inspiration.
Catch the full episode here: